Redox regulation of RAD51 Cys319 and homologous recombination by peroxiredoxin 1.


Journal

Redox biology
ISSN: 2213-2317
Titre abrégé: Redox Biol
Pays: Netherlands
ID NLM: 101605639

Informations de publication

Date de publication:
10 2022
Historique:
received: 05 05 2022
revised: 01 08 2022
accepted: 11 08 2022
pubmed: 5 9 2022
medline: 28 9 2022
entrez: 4 9 2022
Statut: ppublish

Résumé

RAD51 is a critical recombinase that functions in concert with auxiliary mediator proteins to direct the homologous recombination (HR) DNA repair pathway. We show that Cys319 RAD51 possesses nucleophilic characteristics and is important for irradiation-induced RAD51 foci formation and resistance to inhibitors of poly (ADP-ribose) polymerase (PARP). We have previously identified that cysteine (Cys) oxidation of proteins can be important for activity and modulated via binding to peroxiredoxin 1 (PRDX1). PRDX1 reduces peroxides and coordinates the signaling actions of protein binding partners. Loss of PRDX1 inhibits irradiation-induced RAD51 foci formation and represses HR DNA repair. PRDX1-deficient human breast cancer cells and mouse embryonic fibroblasts display disrupted RAD51 foci formation and decreased HR, resulting in increased DNA damage and sensitization of cells to irradiation. Following irradiation cells deficient in PRDX1 had increased incorporation of the sulfenylation probe DAz-2 in RAD51 Cys319, a functionally-significant, thiol that PRDX1 is critical for maintaining in a reduced state. Molecular dynamics (MD) simulations of dT-DNA bound to a non-oxidized RAD51 protein showed tight binding throughout the simulation, while dT-DNA dissociated from an oxidized Cys319 RAD51 filament. These novel data establish RAD51 Cys319 as a functionally-significant site for the redox regulation of HR and cellular responses to IR.

Identifiants

pubmed: 36058112
pii: S2213-2317(22)00215-4
doi: 10.1016/j.redox.2022.102443
pmc: PMC9450138
pii:
doi:

Substances chimiques

Peroxides 0
Poly(ADP-ribose) Polymerase Inhibitors 0
Adenosine Diphosphate 61D2G4IYVH
Ribose 681HV46001
DNA 9007-49-2
Peroxiredoxins EC 1.11.1.15
Poly(ADP-ribose) Polymerases EC 2.4.2.30
RAD51 protein, human EC 2.7.7.-
Rad51 Recombinase EC 2.7.7.-
Rad51 protein, mouse EC 2.7.7.-
Cysteine K848JZ4886

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102443

Subventions

Organisme : NCI NIH HHS
ID : P30 CA047904
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA131350
Pays : United States
Organisme : NCI NIH HHS
ID : R56 CA233817
Pays : United States

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interest.

Auteurs

John J Skoko (JJ)

Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, 15261, USA; Women's Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA, 15213, USA; Magee-Women's Research Institute, Magee-Women's Research Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA.

Juxiang Cao (J)

Department of Cell and Molecular Pharmacology, The Medical University of South Carolina, Charleston, SC, 29425, USA.

David Gaboriau (D)

Centre for Chromosome Biology, School of Natural Sciences, National University of Ireland Galway, Galway, Ireland; Facility for Imaging By Light Microscopy, Imperial College London, London, SW7 2AZ, United Kingdom.

Myriam Attar (M)

Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, 15261, USA; Women's Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA, 15213, USA; Magee-Women's Research Institute, Magee-Women's Research Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA.

Alparslan Asan (A)

Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, 15261, USA; Women's Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA, 15213, USA; Magee-Women's Research Institute, Magee-Women's Research Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA.

Lisa Hong (L)

Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, 15261, USA; Women's Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA, 15213, USA; Magee-Women's Research Institute, Magee-Women's Research Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA.

Candice E Paulsen (CE)

Department of Chemistry, Scripps Research Institute Florida, Jupiter, FL, 33458, USA.

Hongqiang Ma (H)

Biomedical Optical Imaging Laboratory, Departments of Medicine and Bioengineering, University of Pittsburgh, Pittsburgh, PA, 15261, USA.

Yang Liu (Y)

Biomedical Optical Imaging Laboratory, Departments of Medicine and Bioengineering, University of Pittsburgh, Pittsburgh, PA, 15261, USA.

Hanzhi Wu (H)

Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, 27157, USA; Center for Redox Biology and Medicine, Wake Forest School of Medicine, Winston-Salem, NC, 27157, USA.

Trey Harkness (T)

Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, 15261, USA.

Cristina M Furdui (CM)

Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, 27157, USA; Center for Redox Biology and Medicine, Wake Forest School of Medicine, Winston-Salem, NC, 27157, USA.

Yefim Manevich (Y)

Department of Cell and Molecular Pharmacology, The Medical University of South Carolina, Charleston, SC, 29425, USA.

Ciaran G Morrison (CG)

Centre for Chromosome Biology, School of Natural Sciences, National University of Ireland Galway, Galway, Ireland.

Erika T Brown (ET)

Dartmouth Geisel School of Medicine, Hanover, NH, 03755, USA.

Daniel Normolle (D)

Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, 15213, USA.

Maria Spies (M)

Department of Biochemistry and Molecular Biology, University of Iowa, IA, 52242, USA.

Michael Ashley Spies (MA)

Department of Biochemistry and Molecular Biology, Department of Pharmaceutical Sciences and Experimental Therapeutics, University of Iowa, IA, 52242, USA.

Kate Carroll (K)

Department of Chemistry, Scripps Research Institute Florida, Jupiter, FL, 33458, USA.

Carola A Neumann (CA)

Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, 15261, USA; Women's Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA, 15213, USA; Magee-Women's Research Institute, Magee-Women's Research Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA. Electronic address: neumannc@upmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH